SEC Form 3 · accession 0000899243-18-018418
Translate Bio, Inc. · TBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Heartlein
Officer — See Remarks
Period of report
Jun 27, 2018
Accepted (ET)
Jun 27, 2018 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001693415
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 18,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.06 | holding | — | — | — | — | Jun 12, 2027 | Common Stock | 370,695 | — | D |
| Stock Option (right to buy)F2 | $8.34 | holding | — | — | — | — | Mar 6, 2028 | Common Stock | 30,001 | — | D |
Explanation of responses
- F1This option was granted on June 13, 2017. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on December 23, 2017 and the remainder vesting in equal monthly installments through December 23, 2020.
- F2This option was granted on March 7, 2018. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on March 7, 2019 and the remainder vesting in equal monthly installments through March 7, 2022.
Remarks
Chief Scientific Officer and Chief Technical Officer Exhibit Index: 24.1 Power of Attorney